Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 98

1.

[The use of melatonin in the treatment of chronic fatigue syndrome and circadian rhythm disorders in Parkinson's disease].

Datieva VK, Rosinskaia AV, Levin OS.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7 Pt 2):77-81. Russian.

PMID:
23994935
2.

Influence of melatonin on fatigue severity in patients with chronic fatigue syndrome and late melatonin secretion.

van Heukelom RO, Prins JB, Smits MG, Bleijenberg G.

Eur J Neurol. 2006 Jan;13(1):55-60.

PMID:
16420393
3.

Modafinil for Parkinson's disease fatigue.

Tyne HL, Taylor J, Baker GA, Steiger MJ.

J Neurol. 2010 Mar;257(3):452-6. doi: 10.1007/s00415-009-5351-8. Epub 2009 Oct 20.

PMID:
19842011
4.

Therapy of circadian rhythm disorders in chronic fatigue syndrome: no symptomatic improvement with melatonin or phototherapy.

Williams G, Waterhouse J, Mugarza J, Minors D, Hayden K.

Eur J Clin Invest. 2002 Nov;32(11):831-7.

PMID:
12423324
5.
6.

Pretreatment circadian period in free-running blind people may predict the phase angle of entrainment to melatonin.

Lewy AJ, Hasler BP, Emens JS, Sack RL.

Neurosci Lett. 2001 Nov 9;313(3):158-60.

PMID:
11682151
7.

Clinical phenotype of drug-naïve Parkinson's disease based on nonmotor symptoms.

Lee HM, Lee SS, Kim M, Kang SH, Seo WK, Kim JH, Koh SB.

Arch Gerontol Geriatr. 2015 Nov-Dec;61(3):517-22. doi: 10.1016/j.archger.2015.07.001. Epub 2015 Jul 6.

PMID:
26183203
8.

[Sleep disorders in Parkinson's disease without dementia: a comparative randomized controlled study of melatonin and clonazepam].

Litvinenko IV, Krasakov IV, Tikhomirova OV.

Zh Nevrol Psikhiatr Im S S Korsakova. 2012;112(12):26-30. Russian.

PMID:
23388588
9.
10.

Impact of psychiatric symptoms and sleep disorders on the quality of life of patients with Parkinson's disease.

Gómez-Esteban JC, Tijero B, Somme J, Ciordia R, Berganzo K, Rouco I, Bustos JL, Valle MA, Lezcano E, Zarranz JJ.

J Neurol. 2011 Mar;258(3):494-9. doi: 10.1007/s00415-010-5786-y. Epub 2010 Oct 19.

PMID:
20957384
11.

Melatonin for sleep disturbances in Parkinson's disease.

Dowling GA, Mastick J, Colling E, Carter JH, Singer CM, Aminoff MJ.

Sleep Med. 2005 Sep;6(5):459-66.

PMID:
16084125
12.

Disturbances in melatonin secretion and circadian sleep-wake regulation in Parkinson disease.

Bolitho SJ, Naismith SL, Rajaratnam SM, Grunstein RR, Hodges JR, Terpening Z, Rogers N, Lewis SJ.

Sleep Med. 2014 Mar;15(3):342-7. doi: 10.1016/j.sleep.2013.10.016. Epub 2014 Jan 21.

PMID:
24529544
13.

Nocturnal disturbances and restlessness in Parkinson's disease: using the Japanese version of the Parkinson's disease sleep scale-2.

Suzuki K, Miyamoto M, Miyamoto T, Tatsumoto M, Watanabe Y, Suzuki S, Iwanami M, Sada T, Kadowaki T, Numao A, Trenkwalder C, Hirata K.

J Neurol Sci. 2012 Jul 15;318(1-2):76-81. doi: 10.1016/j.jns.2012.03.022. Epub 2012 Apr 23.

PMID:
22534309
14.

The effect of melatonin on sleep and quality of life in patients with advanced breast cancer.

Innominato PF, Lim AS, Palesh O, Clemons M, Trudeau M, Eisen A, Wang C, Kiss A, Pritchard KI, Bjarnason GA.

Support Care Cancer. 2016 Mar;24(3):1097-105. doi: 10.1007/s00520-015-2883-6. Epub 2015 Aug 11.

PMID:
26260726
15.

Independent effect of fatigue on health-related quality of life in patients with idiopathic Parkinson's disease.

Dogan VB, Koksal A, Dirican A, Baybas S, Dirican A, Dogan GB.

Neurol Sci. 2015 Dec;36(12):2221-6. doi: 10.1007/s10072-015-2340-9. Epub 2015 Jul 22.

PMID:
26198763
16.

Dissociation of body-temperature and melatonin secretion circadian rhythms in patients with chronic fatigue syndrome.

Williams G, Pirmohamed J, Minors D, Waterhouse J, Buchan I, Arendt J, Edwards RH.

Clin Physiol. 1996 Jul;16(4):327-37.

PMID:
8842569
17.

beta(1)-adrenergic antagonists improve sleep and behavioural disturbances in a circadian disorder, Smith-Magenis syndrome.

De Leersnyder H, de Blois MC, Vekemans M, Sidi D, Villain E, Kindermans C, Munnich A.

J Med Genet. 2001 Sep;38(9):586-90.

18.

Beta 1-adrenergic antagonists and melatonin reset the clock and restore sleep in a circadian disorder, Smith-Magenis syndrome.

De Leersnyder H, Bresson JL, de Blois MC, Souberbielle JC, Mogenet A, Delhotal-Landes B, Salefranque F, Munnich A.

J Med Genet. 2003 Jan;40(1):74-8. No abstract available.

19.

Health-related quality of life and sleep disorders in Parkinson's disease.

Scaravilli T, Gasparoli E, Rinaldi F, Polesello G, Bracco F.

Neurol Sci. 2003 Oct;24(3):209-10.

PMID:
14598091
20.

Role of melatonin in the regulation of human circadian rhythms and sleep.

Cajochen C, Kräuchi K, Wirz-Justice A.

J Neuroendocrinol. 2003 Apr;15(4):432-7. Review.

PMID:
12622846

Supplemental Content

Support Center